Robberecht P, Delhaye M, Taton G, De Neef P, Waelbroeck M, De Smet J M, Leclerc J L, Chatelain P, Christophe J
Mol Pharmacol. 1983 Sep;24(2):169-73.
Beta-adrenergic receptors were characterized in a particulate fraction of human auricles obtained from patients operated upon for coronary insufficiency or valvular disease. [125I] Hydroxybenzylpindolol binding was evaluated in terms of kinetics; KD and Bmax values; and inhibition of binding in the presence of 10 microM GTP and of increasing concentrations of four nonselective agonists giving a Hill coefficient of 1 (isoproterenol, salbutamol, fenoterol, and epinephrine), of two nonselective antagonists giving a Hill coefficient of 1 (pindolol and propranolol), and of a series of selective drugs giving a Hill coefficient of 0.60-0.72 that included three beta 1-selective antagonists (practolol, metoprolol, and atenolol) and two beta 2- selective agonists (procaterol and zinterol). KD values for all drugs were compatible with the coexistence in membranes from human auricles of beta 1- and beta 2-adrenergic receptors, the relative proportions of receptors of each subclass being approximately the same.
在因冠状动脉供血不足或瓣膜疾病而接受手术的患者所获取的人耳廓微粒部分中,对β-肾上腺素能受体进行了特性研究。通过动力学、KD和Bmax值以及在存在10微摩尔GTP和浓度不断增加的四种非选择性激动剂(其希尔系数为1,即异丙肾上腺素、沙丁胺醇、非诺特罗和肾上腺素)、两种非选择性拮抗剂(其希尔系数为1,即吲哚洛尔和普萘洛尔)以及一系列希尔系数为0.60 - 0.72的选择性药物(包括三种β1选择性拮抗剂,即普拉洛尔、美托洛尔和阿替洛尔,以及两种β2选择性激动剂,即丙卡特罗和辛特罗)的情况下对结合的抑制作用,评估了[125I]羟基苄基吲哚洛尔的结合情况。所有药物的KD值与在人耳廓膜中β1和β2肾上腺素能受体共存情况相符,每个亚类受体相对比例大致相同。